Identification of Interconnected Markers for T-Cell Acute Lymphoblastic Leukemia
暂无分享,去创建一个
Ozlem Keskin | Attila Gursoy | O. Keskin | A. Gursoy | Emine Guven Maiorov | Ozden Hatirnaz Ng | U. Ozbek | Ugur Ozbek | Emine Guven Maiorov | Ozden Hatirnaz Ng | E. Guven Maiorov
[1] M. Greaves,et al. Altered adhesive interactions with marrow stroma of haematopoietic progenitor cells in chronic myeloid leukaemia , 1987, Nature.
[2] Lodewyk F. A. Wessels,et al. A Critical Evaluation of Network and Pathway-Based Classifiers for Outcome Prediction in Breast Cancer , 2011, PloS one.
[3] Peter Marynen,et al. Fusion of EML1 to ABL1 in T-cell acute lymphoblastic leukemia with cryptic t(9;14)(q34;q32). , 2005, Blood.
[4] G. Gamble,et al. Chromosome 4q31 locus in COPD is also associated with lung cancer , 2010, European Respiratory Journal.
[5] Doheon Lee,et al. Inferring Pathway Activity toward Precise Disease Classification , 2008, PLoS Comput. Biol..
[6] R. Foà,et al. Myeloid/T-cell acute lymphoblastic leukemia in children and adults , 2011, Pediatric reports.
[7] Y. Mo,et al. Targeting Ubc9 for cancer therapy , 2005, Expert opinion on therapeutic targets.
[8] F. Staal,et al. The canonical Wnt signaling pathway plays an important role in lymphopoiesis and hematopoiesis , 2008, European journal of immunology.
[9] C. Sawyers,et al. Targeted cancer therapy , 2004, Nature.
[10] A. Borkhardt,et al. The human LASP1 gene is fused to MLL in an acute myeloid leukemia with t(11;17)(q23;q21) , 2003, Oncogene.
[11] P. Marynen,et al. Recurrent rearrangement of the Ewing's sarcoma gene, EWSR1, or its homologue, TAF15, with the transcription factor CIZ/NMP4 in acute leukemia. , 2002, Cancer research.
[12] W. Bal,et al. Damage of zinc fingers in DNA repair proteins, a novel molecular mechanism in carcinogenesis. , 2006, Toxicology letters.
[13] Expression of P2X7 receptor increases in vivo tumor growth. , 2012, Cancer research.
[14] A. Noël,et al. Enhanced Activity of Meprin-α, a Pro-Migratory and Pro-Angiogenic Protease, in Colorectal Cancer , 2011, PloS one.
[15] R. Coutinho-Silva,et al. Extracellular ATP induces cell death in human intestinal epithelial cells. , 2012, Biochimica et biophysica acta.
[16] Trey Ideker,et al. An Integrated Systems Analysis Implicates EGR1 Downregulation in Simian Immunodeficiency Virus Encephalitis-Induced Neural Dysfunction , 2009, The Journal of Neuroscience.
[17] Xiaoyan Song,et al. Simultaneous detection of MDR1 and WT1 gene expression to predict the prognosis of adult acute lymphoblastic leukemia , 2010, Hematology.
[18] E. Petricoin,et al. Mapping molecular networks using proteomics: a vision for patient-tailored combination therapy. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[19] H. Nakauchi,et al. Plasmin inhibitor reduces T-cell lymphoid tumor growth by suppressing matrix metalloproteinase-9-dependent CD11b+/F4/80+ myeloid cell recruitment , 2012, Leukemia.
[20] S. Loh. The missing zinc: p53 misfolding and cancer. , 2010, Metallomics : integrated biometal science.
[21] Yusuke Nakamura,et al. Isolation and characterization of a novel human gene, VANGL1, as a therapeutic target for hepatocellular carcinoma. , 2002, International journal of oncology.
[22] E. Raetz,et al. Molecular pathogenesis of T-cell leukaemia and lymphoma , 2008, Nature Reviews Immunology.
[23] G. Gordon,et al. Phase 1 Study of ABT-751, a Novel Microtubule Inhibitor, in Patients with Refractory Hematologic Malignancies , 2005, Clinical Cancer Research.
[24] D. Botstein,et al. Cluster analysis and display of genome-wide expression patterns. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[25] R. Juliano,et al. Clinging to life: cell to matrix adhesion and cell survival , 2005, Cancer and Metastasis Reviews.
[26] M. Gerstein,et al. Relating whole-genome expression data with protein-protein interactions. , 2002, Genome research.
[27] P. Marynen,et al. Genetic insights in the pathogenesis of T-cell acute lymphoblastic leukemia. , 2005, Haematologica.
[28] H. Ploegh,et al. Activity-based ubiquitin-specific protease (USP) profiling of virus-infected and malignant human cells. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[29] B. Löwenberg,et al. A decade of genome-wide gene expression profiling in acute myeloid leukemia: flashback and prospects. , 2009, Blood.
[30] Z. Estrov,et al. SSBP2 is an in vivo tumor suppressor and regulator of LDB1 stability , 2010, Oncogene.
[31] L. Romer,et al. Inhibition of focal adhesion kinase (FAK) signaling in focal adhesions decreases cell motility and proliferation. , 1996, Molecular biology of the cell.
[32] G. Rubanyi,et al. Hedgehog-interacting protein is highly expressed in endothelial cells but down-regulated during angiogenesis and in several human tumors , 2004, BMC Cancer.
[33] A. Maitra,et al. Aberrant methylation of the human hedgehog interacting protein (HHIP) gene in pancreatic neoplasms , 2005, Cancer biology & therapy.
[34] J. Raser,et al. Noise in Gene Expression: Origins, Consequences, and Control , 2005, Science.
[35] Pall I. Olason,et al. A human phenome-interactome network of protein complexes implicated in genetic disorders , 2007, Nature Biotechnology.
[36] Ron Shamir,et al. EXPANDER – an integrative program suite for microarray data analysis , 2005, BMC Bioinformatics.
[37] E. Lander,et al. Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[38] F. Sigaux,et al. HOXA genes are included in genetic and biologic networks defining human acute T-cell leukemia (T-ALL). , 2005, Blood.
[39] Yi Zhang,et al. Leukaemic transformation by CALM–AF10 involves upregulation of Hoxa5 by hDOT1L , 2006, Nature Cell Biology.
[40] Shi-Hua Zhang,et al. Detecting disease associated modules and prioritizing active genes based on high throughput data , 2010, BMC Bioinformatics.
[41] L. Zitvogel,et al. Loss-of-function alleles of P2RX7 and TLR4 fail to affect the response to chemotherapy in non-small cell lung cancer , 2012, Oncoimmunology.
[42] E. Sterchi,et al. Activation of Human Meprin-α in a Cell Culture Model of Colorectal Cancer Is Triggered by the Plasminogen-activating System* , 2002, The Journal of Biological Chemistry.
[43] E. Lander,et al. A molecular signature of metastasis in primary solid tumors , 2003, Nature Genetics.
[44] E. Lander,et al. Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia. , 2002, Cancer cell.
[45] Robert Clarke,et al. Identifying protein interaction subnetworks by a bagging Markov random field-based method , 2012, Nucleic acids research.
[46] Pablo Tamayo,et al. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[47] Neil O. Carragher,et al. The role of focal-adhesion kinase in cancer — a new therapeutic opportunity , 2005, Nature Reviews Cancer.
[48] M. Malavolta,et al. Zinc-binding proteins (metallothionein and α-2 macroglobulin) and immunosenescence , 2006, Experimental Gerontology.
[49] E. Macintyre,et al. CALM-AF10+ T-ALL expression profiles are characterized by overexpression of HOXA and BMI1 oncogenes , 2005, Leukemia.
[50] Yun Li,et al. Dynamic modular architecture of protein-protein interaction networks beyond the dichotomy of ‘date' and ‘party' hubs , 2013, Scientific Reports.
[51] F. Staal,et al. Signaling pathways involved in the development of T-cell acute lymphoblastic leukemia , 2008, Haematologica.
[52] Sandhya Rani,et al. Human Protein Reference Database—2009 update , 2008, Nucleic Acids Res..
[53] M. Schlesinger,et al. The complement system is defective in chronic lymphatic leukemia patients and in their healthy relatives. , 1996, Leukemia.
[54] Xiao-tong Ma,et al. Expression of P2X7 in human hematopoietic cell lines and leukemia patients. , 2004, Leukemia research.
[55] Torsten Haferlach,et al. Modern diagnostics in acute leukemias. , 2005, Critical reviews in oncology/hematology.
[56] A. Yakovlev,et al. How high is the level of technical noise in microarray data? , 2007, Biology Direct.
[57] David Warde-Farley,et al. Dynamic modularity in protein interaction networks predicts breast cancer outcome , 2009, Nature Biotechnology.
[58] T. Ideker,et al. Network-based classification of breast cancer metastasis , 2007, Molecular systems biology.
[59] TaeHyun Hwang,et al. Learning on Weighted Hypergraphs to Integrate Protein Interactions and Gene Expressions for Cancer Outcome Prediction , 2008, 2008 Eighth IEEE International Conference on Data Mining.
[60] K. Ohshima,et al. Elevated expression of CCL5/RANTES in adult T‐cell leukemia cells: Possible transactivation of the CCL5 gene by human T‐cell leukemia virus type I tax , 2004, International journal of cancer.
[61] W. Hiddemann,et al. CLINICAL OBSERVATIONS, INTERVENTIONS, AND THERAPEUTIC TRIALS Global approach to the diagnosis of leukemia using gene expression profiling , 2022 .
[62] A. Aderem. Systems Biology: Its Practice and Challenges , 2005, Cell.
[63] U. Ertem,et al. High Prevelance of Chronic Magnesium Deficiency in T Cell Lymphoblastic Leukemia and Chronic Zinc Deficiency in Children with Acute Lymphoblastic Leukemia and Malignant Lymphoma , 2000, Leukemia & lymphoma.
[64] J. S. Bond,et al. Meprins, membrane-bound and secreted astacin metalloproteinases. , 2008, Molecular aspects of medicine.
[65] Ka Yee Yeung,et al. The derivation of diagnostic markers of chronic myeloid leukemia progression from microarray data. , 2009, Blood.
[66] J. Cigudosa,et al. NUP98 is fused to adducin 3 in a patient with T-cell acute lymphoblastic leukemia and myeloid markers, with a new translocation t(10;11)(q25;p15). , 2003, Cancer research.
[67] R. Letón,et al. Tumoral and tissue‐specific expression of the major human β‐tubulin isotypes , 2010, Cytoskeleton.
[68] F. Di Virgilio,et al. Expression of the P2X7 Receptor Increases the Ca2+ Content of the Endoplasmic Reticulum, Activates NFATc1, and Protects from Apoptosis* , 2009, Journal of Biological Chemistry.
[69] O. Louthan. Chromogranin a in physiology and oncology. , 2011, Folia biologica.
[70] Y. Tu,et al. Quantitative noise analysis for gene expression microarray experiments , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[71] G. Eby. Treatment of acute lymphocytic leukemia using zinc adjuvant with chemotherapy and radiation--a case history and hypothesis. , 2005, Medical hypotheses.
[72] D. Goldenberg,et al. Expression patterns of CEACAM5 and CEACAM6 in primary and metastatic cancers , 2007, BMC Cancer.
[73] J. Rey,et al. Human hedgehog interacting protein expression and promoter methylation in medulloblastoma cell lines and primary tumor samples , 2011, Journal of Neuro-Oncology.
[74] Benno Schwikowski,et al. Discovering regulatory and signalling circuits in molecular interaction networks , 2002, ISMB.
[75] M. Vidal. A Biological Atlas of Functional Maps , 2001, Cell.
[76] A. Joe,et al. Mechanisms of Disease: oncogene addiction—a rationale for molecular targeting in cancer therapy , 2006, Nature Clinical Practice Oncology.
[77] C. Moreno. The Sex-determining region Y-box 4 and homeobox C6 transcriptional networks in prostate cancer progression: crosstalk with the Wnt, Notch, and PI3K pathways. , 2010, The American journal of pathology.
[78] Z. Fishelson,et al. Complement resistance of tumor cells: basal and induced mechanisms. , 1999, Molecular immunology.
[79] Jingchun Chen,et al. Detecting functional modules in the yeast protein-protein interaction network , 2006, Bioinform..
[80] Shanghua Yin,et al. Human Mutations That Confer Paclitaxel Resistance , 2010, Molecular Cancer Therapeutics.
[81] Trey Ideker,et al. Testing for Differentially-Expressed Genes by Maximum-Likelihood Analysis of Microarray Data , 2000, J. Comput. Biol..
[82] J. S. Bond,et al. Meprin metalloprotease expression and regulation in kidney, intestine, urinary tract infections and cancer , 2005, FEBS letters.
[83] O. Yokosuka,et al. Down-Regulation of Hedgehog-Interacting Protein through Genetic and Epigenetic Alterations in Human Hepatocellular Carcinoma , 2008, Clinical Cancer Research.
[84] A. Hagemeijer,et al. Cytogenetics and molecular genetics of T-cell acute lymphoblastic leukemia: from thymocyte to lymphoblast , 2006, Leukemia.
[85] M. Malavolta,et al. Zinc-binding proteins (metallothionein and alpha-2 macroglobulin) and immunosenescence. , 2006, Experimental Gerontology.
[86] Yang Chen,et al. Open Access Research Article Identification of Responsive Gene Modules by Network-based Gene Clustering and Extending: Application to Inflammation and Angiogenesis , 2022 .
[87] Torsten Haferlach,et al. An international standardization programme towards the application of gene expression profiling in routine leukaemia diagnostics: the Microarray Innovations in LEukemia study prephase , 2008, British journal of haematology.
[88] Lan V. Zhang,et al. Evidence for dynamically organized modularity in the yeast protein–protein interaction network , 2004, Nature.
[89] Rod K. Nibbe,et al. Approaches to biomarkers in human colorectal cancer: looking back, to go forward. , 2009, Biomarkers in medicine.
[90] 中尾 光輝,et al. KEGG(Kyoto Encyclopedia of Genes and Genomes)〔和文〕 (特集 ゲノム医学の現在と未来--基礎と臨床) -- (データベース) , 2000 .
[91] A. Statnikov,et al. The Notch/Hes1 pathway sustains NF-κB activation through CYLD repression in T cell leukemia. , 2010, Cancer cell.
[92] M. Elghetany,et al. CD36: a multiligand molecule. , 2005, Laboratory hematology : official publication of the International Society for Laboratory Hematology.
[93] Haidong Wang,et al. Discovering molecular pathways from protein interaction and gene expression data , 2003, ISMB.
[94] Ash A. Alizadeh,et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling , 2000, Nature.
[95] M. Ranson,et al. Plasminogen binding and cancer: promises and pitfalls. , 2003, Frontiers in bioscience : a journal and virtual library.
[96] Nir Friedman,et al. Tissue classification with gene expression profiles. , 2000 .
[97] J. Singer,et al. A functional defect in irradiated adherent layers from chronic myelogenous leukemia long-term marrow cultures. , 1985, Experimental hematology.
[98] Ian H. Witten,et al. The WEKA data mining software: an update , 2009, SKDD.
[99] G. Basso,et al. CD99 expression in T-lineage ALL: implications for flow cytometric detection of minimal residual disease , 2004, Leukemia.
[100] Z. Fishelson,et al. Phosphorylation of the complement component, C9, by an ecto-protein kinase of human leukemic cells. , 1999, Immunopharmacology.
[101] J. Collins,et al. A network biology approach to prostate cancer , 2007, Molecular systems biology.
[102] G. Gordon,et al. Phase1Study of ABT-751, a NovelMicrotubule Inhibitor, in Patients with Refractory HematologicMalignancies , 2005 .
[103] Michael Recce,et al. Noise filtering and nonparametric analysis of microarray data underscores discriminating markers of oral, prostate, lung, ovarian and breast cancer , 2004, BMC Bioinformatics.
[104] A. Ferrando,et al. Fusion of NUP214 to ABL1 on amplified episomes in T-cell acute lymphoblastic leukemia , 2004, Nature Genetics.
[105] E. Dougherty,et al. Accurate and Reliable Cancer Classification Based on Probabilistic Inference of Pathway Activity , 2009, PloS one.
[106] J. Wiley,et al. A loss-of-function polymorphic mutation in the cytolytic P2X7 receptor gene and chronic lymphocytic leukaemia: a molecular study , 2002, The Lancet.
[107] T. Marafioti,et al. Focal adhesion kinase (FAK) expression in normal and neoplastic lymphoid tissues. , 2009, Pathology, research and practice.
[108] T. Lebien,et al. Contact between human bone marrow stromal cells and B lymphocytes enhances very late antigen-4/vascular cell adhesion molecule-1-independent tyrosine phosphorylation of focal adhesion kinase, paxillin, and ERK2 in stromal cells. , 1997, Blood.
[109] D. Hanahan,et al. The Hallmarks of Cancer , 2000, Cell.
[110] F. Di Virgilio,et al. P2X7 receptor expression in evolutive and indolent forms of chronic B lymphocytic leukemia. , 2002, Blood.
[111] J. Mesirov,et al. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. , 1999, Science.
[112] L. Padyukov,et al. Polymorphism in the P2X7 receptor gene and survival in chronic lymphocytic leukaemia , 2002, The Lancet.
[113] Jing Wang,et al. PQN and DQN: algorithms for expression microarrays. , 2006, Journal of theoretical biology.
[114] Emmanuel Barillot,et al. Classification of microarray data using gene networks , 2007, BMC Bioinformatics.
[115] M. Schaller,et al. FAK regulates biological processes important for the pathogenesis of cancer , 2003, Cancer and Metastasis Reviews.
[116] T. Hoang,et al. The T-ALL paradox in cancer , 2010, Nature Medicine.
[117] R. Pieters,et al. Molecular‐genetic insights in paediatric T‐cell acute lymphoblastic leukaemia , 2008, British journal of haematology.
[118] Serban Nacu,et al. Gene expression network analysis and applications to immunology , 2007, Bioinform..
[119] F. Di Virgilio,et al. A His-155 to Tyr Polymorphism Confers Gain-of-Function to the Human P2X7 Receptor of Human Leukemic Lymphocytes1 , 2005, The Journal of Immunology.
[120] S. Shurtleff,et al. Clinical utility of microarray-based gene expression profiling in the diagnosis and subclassification of leukemia: report from the International Microarray Innovations in Leukemia Study Group. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.